Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1982-10-21
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0360-3016
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
903-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6809711-Altretamine,
pubmed-meshheading:6809711-Cisplatin,
pubmed-meshheading:6809711-Cyclophosphamide,
pubmed-meshheading:6809711-Doxorubicin,
pubmed-meshheading:6809711-Drug Therapy, Combination,
pubmed-meshheading:6809711-Female,
pubmed-meshheading:6809711-Humans,
pubmed-meshheading:6809711-Ovarian Neoplasms
|
pubmed:year |
1982
|
pubmed:articleTitle |
Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma.
|
pubmed:publicationType |
Journal Article
|